CompletedNot Applicable

Effect of Physiotherapy and Rehabilitation Program on Physical Activity Level in the Elderly Inpatient

323 participantsStarted 2015-01-01

Plain-language summary

In inpatient older adults, decrement in their mobility and loss in their physical activity are seen in time line between their hospitalization and discharge. The aim of our study was to investigate the effect of physiotherapy and rehabilitation program on physical activity, functional skills and quality of life in elderly inpatient. A total of 124 patients who were randomized as study and control group followed by Hacettepe University Faculty of Medicine Department of Internal Medicine, Division of Geriatric Medicine were included to the study. Thirty minutes physiotherapy and rehabilitation program was applied to the patients in the study group according to their functional levels. Geriatric patients in the control group did exercises by themselves. Demographic data, cognitive functions, muscle strength, presence of comorbidity, functional mobility, physical activity, daily living activities, fear of fall, quality of life and depression status were assessed of all cases. Activities of daily living and depression status was questioned again three months later. This study evaluated the efficacy and cost effectiveness of increasing physical activity in older people during inpatient rehabilitation. These results could assist in the development of evidenced-based rehabilitation programs for this population.

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Aged 65 years or older * Mini Mental State Examination score greater than 24; * Stayed in the hospital at least 48 hours. Exclusion Criteria : * Angiina pectoris, acute myocarditis, myocardial infarction story in the last 3 months, * Pulmonary embolism and deep vein thrombosis within the last 3 months, * Active infection, * Malignancy and terminal disease status, * Fracture story in the lower and upper extremities in the last three months * Severe hearing and visual loss.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

DEMMI-De Morton Mobility Scale

Timeframe: 5 DAYS

EQ5D-EQ-5D EuroQool Health Quality Assesment

Timeframe: 5 DAYS

PAIR-Physical Activity in Inpatient Rehabilitation Assessment

Timeframe: 5 DAYS

Trial details

NCT IDNCT03516032

SponsorHacettepe University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-09-15

View on ClinicalTrials.gov More Hospitalism trials

Plain-language summary

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.